Memantine in Adult Autism Spectrum Disorder

NATerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
AutismAsperger's DisorderPervasive Developmental Disorder NOS
Interventions
DRUG

memantine

memantine 5-20 mg daily

DRUG

Placebo

Look-alike placebo

Trial Locations (1)

21287

Johns Hopkins Bayview, Baltimore

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Forest Laboratories

INDUSTRY

lead

Johns Hopkins University

OTHER